Approval · Notice of Compliance 31194 · 2023
PEPCID COMPLETE: Notice of Compliance 31194
Issued July 11, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31194
- Date
- July 11, 2023
- Company
- McNeil Consumer Healthcare, division of Johnson & Johnson Inc.Markham, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety update to the Product Monograph. Updates to the product monograph.Update to the Package Insert and outer labels
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PEPCID COMPLETE | Not yet assigned | — |
Medicinal ingredients
- CALCIUM CARBONATE 800 MG per TAB
- FAMOTIDINE 10 MG per TAB
- MAGNESIUM HYDROXIDE 165 MG per TAB